Lv449
468 积分 2025-11-28 加入
Lessons learned in linking PROTACs from discovery to the clinic
10天前
已完结
Risk of Formaldehyde Contamination in Amines from Residual Dichloromethane
19天前
已完结
Chiral Inversion and Hydrolysis of Thalidomide: Mechanisms and Catalysis by Bases and Serum Albumin, and Chiral Stability of Teratogenic Metabolites
23天前
已完结
Carboxylic Acid Counterions in FDA-Approved Pharmaceutical Salts
1个月前
已完结
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective
1个月前
已完结
Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
1个月前
已完结
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
1个月前
已完结
Discovery of KRAS(G12D) selective degrader ASP3082
1个月前
已完结
Discovery of a bifunctional PKMYT1-targeting PROTAC empowered by AI-generation
1个月前
已完结
Hydrogen-Bond Donors in Drug Design
1个月前
已完结
皖公网安备34019202002308
